Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05818332

ClassIntra® for Better Outcomes in Surgery - CIBOSurg

Implementation of Routine Recording of Intraoperative Adverse Events According to ClassIntra® During the Sign-out Phase of the WHO Surgical Safety Checklist Using a Multifaceted, Tailored Implementation Strategy: Protocol of a Collaborative Before- and After-cohort Project

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,800 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years – 110 Years
Healthy volunteers
Not accepted

Summary

Intra- and postoperative adverse events (iAEs and pAEs) occur in up to one third of all patients undergoing surgery. They are devastating to patients and costly to health care systems. Their number tends to increase due to the rising complexity of both the patient's risk profile and the surgical procedure. Postoperative deaths have been identified to be the third most frequent cause of death worldwide. Teamwork in surgery has been attributed to have a potentially great impact on avoiding postoperative morbidity. Up to 50% of all adverse in-hospital events were rated to be potentially preventable. However, their prevention typically requires a change in systems and individual behaviour. Standardised assessments of iAEs and pAEs are a prerequisite to develop and define strategies for prevention of AEs. While awareness of pAEs has highly risen through the introduction of the Clavien-Dindo classification, the most widely used classification for grading severity of pAEs, the relevance of transparent monitoring of iAEs is still highly undervalued.

Conditions

Interventions

TypeNameDescription
OTHERObservational studyNo intervention, observational only

Timeline

Start date
2023-07-17
Primary completion
2025-12-01
Completion
2027-07-01
First posted
2023-04-18
Last updated
2025-02-11

Locations

10 sites across 2 countries: Netherlands, Switzerland

Source: ClinicalTrials.gov record NCT05818332. Inclusion in this directory is not an endorsement.